source
- AbbVie’s once-daily Parkinson’s pill receives FDA approvalAbbVie announced that the U.S. Food and Drug Administration has granted approval for its once‑daily oral therapy for Parkinson’s disease. The decision allows the product to be marketed in the Unite…
- AI tools that aid vaccine design could also accelerate creation of bioweapons, warns former White House Covid adviserAshish K. Jha, a former White House Covid‑19 response coordinator and senior fellow at Harvard Kennedy School, cautions that artificial intelligence is lowering the barriers that kept biological we…